RAMM Pharma Corp.
RAMM
CNSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 57.61% | -196.40% | 6.81% | -48.13% | -37.75% |
| Total Depreciation and Amortization | -26.44% | 23.58% | -14.48% | -28.09% | -6.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -102.71% | 284.00% | 31.47% | 7.22% | 323.42% |
| Change in Net Operating Assets | 4,346.67% | 3,116.35% | -216.44% | 148.09% | -211.11% |
| Cash from Operations | 79.31% | 54.42% | -71.37% | 15.55% | -5.86% |
| Capital Expenditure | -83.33% | 58.55% | -- | 95.45% | -88.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -122.94% | -124.14% | 1.90% | 200.72% |
| Cash from Investing | -154.66% | -124.36% | -163.36% | 46.35% | -23.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -11.90% | 7.54% | -23.88% | 1.70% | 35.06% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -25.68% | 31.71% | 21.74% | -- |
| Cash from Financing | -6.24% | -4.43% | 63.95% | 7.14% | 60.47% |
| Foreign Exchange rate Adjustments | 206.00% | -91.63% | 132.43% | 234.04% | -869.23% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 74.09% | 44.15% | -47.96% | 17.79% | -0.72% |